ABOUT PAREXEL INTERNATIONAL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart®. We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships. For more information, visit parexel.com and follow us on LinkedIn, X, Facebook and Instagram.
CONTACT INFORMATION
Parexel International
541 Church at North Hills St., Suite 1000
Raleigh, NC 27609
UNITED STATES
INDUSTRY INSIGHTS
-
![Malaysia - care worker with patient in a wheelchair (high res)]( "Strategies To Win Breakthrough Designation In Rare Disease Programs")
Breakthrough designation can unlock faster paths for rare disease therapies. Learn how smart timing, compelling evidence, and early regulatory alignment can turn promising science into accelerated patient impact.
-
![Female patient consults with an HCP during in-home visit (high res)]( "5 Strategies For Designing Successful Complex Rare Disease Trials")
Rare disease trials demand inventive design. Uncover creative strategies that help sponsors overcome tiny populations, complex endpoints, and operational hurdles to advance meaningful breakthroughs.
-
![APAC - elderly woman gets help from her daughter with her cap (high res)]( "5 RWE Approaches That Strengthen Precision Oncology")
Real-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.
-
![Elderly oncology patient at her window (high res)]( "Accelerating Oncology Drug Development Through Innovative Designs")
Adaptive and novel trial designs are redefining oncology development, powering faster decisions with smarter flexibility. Discover innovative approaches that elevate efficiency while safeguarding scientific rigor.
-
![Senior patient gazing out window in hospital room (high res)]( "Mastering Precision Oncology Start-Up: Reducing Screening Delays")
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
